Rocaglamide
CAS: 84573-16-0
Ref. 3D-JDA57316
| 1mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
Rocaglamide
Sinónimos:
- 1H-Cyclopenta[b]benzofuran-2-carboxamide, 2,3,3a,8b-tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-, [1R-(1α,2α,3β,3aβ,8bβ)]-
- NSC 326408
- (1R,2R,3S,3aR,8bS)-2,3,3a,8b-Tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-1H-cyclopenta[b]benzofuran-2-carboxamide
- 1H-Cyclopenta[b]benzofuran-2-carboxamide, 2,3,3a,8b-tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-, (1R,2R,3S,3aR,8bS)-
Descrição:
Rocaglamide is a synthetic compound that inhibits the mitochondrial membrane potential and induces apoptosis pathways. This compound also has potent antitumor activity in vivo, which may be due to its ability to inhibit the synthesis of DNA, RNA and protein in tumor cells. Rocaglamide inhibits cancer cells by inhibiting the production of ATP, which leads to cell death through necrosis or apoptosis. The hydroxyl group on rocaglamide's structure is thought to be responsible for its antitumor activity.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
505.56 g/mol
Fórmula:
C29H31NO7
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
